Publication | Closed Access

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

VaccinationParasitic ProtozoaImmunologyImmunodominanceTherapeutic VaccineAutoimmunityT Cell ImmunityTh1 TypeVaccine DesignLeishmania Major InducesMedicineVisceral LeishmaniasisParasitology